Health Care & Life Sciences » Biotechnology | PTC Therapeutics Inc.

PTC Therapeutics Inc.

PTC Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.21 M
Public Float
38.91 M
PTC Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.52
Market Cap
$2.58 B
Shares Outstanding
58.43 M
Public Float
55.51 M

Profile

Address
100 Corporate Court
South Plainfield New Jersey 07080
United States
Employees -
Website http://www.ptcbio.com
Updated 07/08/2019
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders.

Financials

View All

Stuart W. Peltz
Chief Executive Officer & Director
Michael Schmertzler
Chairman